시장보고서

상품코드

1631227

심장 바이오마커 진단 검사 키트 시장 - 세계 산업 분석, 규모, 점유율, 성장, 동향, 예측(2032년)

Cardiac Biomarker Diagnostic Test Kits Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2032

발행일: 2025년 01월 | 리서치사:

Fairfield Market Research | 페이지 정보: 영문 209 Pages | 배송안내 : 2-5일 (영업일 기준)

샘플 요청 목록에 추가

※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

심장 바이오마커 진단 검사 키트 시장은 심혈관질환에 대한 인식이 높아지고 진단 기술이 발전함에 따라 큰 성장이 예상됩니다. 이러한 키트는 심장 관련 질환의 조기 발견 및 관리에 필수적이며, 적시에 개입하여 환자의 결과를 개선할 수 있도록 돕습니다. 심장 바이오마커 진단 검사 키트 시장 규모는 2023년부터 2032년까지 연평균 5.70%의 안정적인 CAGR로 성장하여 2025년에는 18억 9,000만 달러, 2032년에는 27억 9,000만 달러에 달할 것으로 예상됩니다.

이러한 진단 솔루션에 대한 수요는 생활습관 관련 건강 위험과 전 세계 인구의 고령화가 결합되어 심혈관 건강 문제를 해결하기 위한 혁신적인 도구에 대한 긴급한 요구가 발생하고 있습니다. 심장 바이오마커 진단 검사 키트 시장은 혁신적이고 정확하며 시기적절한 진단 도구에 대한 수요가 증가함에 따라 강력한 성장세를 보일 것으로 예상되며, POC 테스트, AI 통합, 신흥 시장에서의 기회 확대로 심혈관 치료를 혁신하고 전 세계 건강 결과를 개선하는 데 기여할 것으로 전망됩니다. 개선할 수 있는 궤도에 올라서고 있습니다.

심근경색, 심부전 등 심혈관질환의 발병률 증가는 시장 성장의 주요 촉진요인입니다. 심장 바이오마커 검사 키트는 조기 발견을 가능하게 하고 이러한 중요한 질병을 효과적으로 관리할 수 있도록 돕습니다. 고감도 분석과 다중 면역분석의 혁신으로 심장 바이오마커 검사의 정확성과 효율성이 향상되어 의료 종사자들 사이에서 채택이 증가하고 있습니다. 조기 발견의 중요성에 대한 의료 전문가와 환자들의 인식이 높아지면서 심장 바이오마커 진단 검사 키트에 대한 수요가 증가하고 있습니다.

이 보고서는 세계 심장 바이오마커 진단 검사 키트 시장에 대해 조사했으며, 시장 개요와 함께 제품 유형별, 적응증별, 최종 용도별, 지역별 동향, 시장 진입 기업의 경쟁 동향 등을 정리하여 전해드립니다.

세계의 심장 바이오마커 진단 검사 키트 시장 전망, 제품 유형별, 금액(10억 달러), 2019-2032년
세계의 심장 바이오마커 진단 검사 키트 시장 전망, 적응증별, 금액(10억 달러), 2019-2032년
세계의 심장 바이오마커 진단 검사 키트 시장 전망, 최종 용도별, 금액(10억 달러), 2019-2032년
세계의 심장 바이오마커 진단 검사 키트 시장 전망, 지역별, 금액(10억 달러), 2019-2032년

제4장 북미의 심장 바이오마커 진단 검사 키트 시장 전망, 2019-2032년

제5장 유럽의 심장 바이오마커 진단 검사 키트 시장 전망, 2019-2032년

제6장 아시아태평양의 심장 바이오마커 진단 검사 키트 시장 전망, 2019-2032년

제7장 라틴아메리카의 심장 바이오마커 진단 검사 키트 시장 전망, 2019-2032년

제8장 중동 및 아프리카의 심장 바이오마커 진단 검사 키트 시장 전망, 2019-2032년

제9장 경쟁 구도

최종 용도별 vs 적응증별 히트맵
제조업체별 vs 적응증별 히트맵
기업 시장 점유율 분석, 2024년
경쟁 대시보드
기업 개요
- Abbott Laboratories
- Danaher Corporation
- Bio-Rad Laboratories
- Thermo Fisher Scientific, Inc.
- Becton, Dickinson and Company
- F. Hoffmann-La Roche Ltd.
- Siemens AG
- BioMerieux SA
- Randox Laboratories Ltd.
- 기타

제10장 부록

ksm 25.01.23

The cardiac biomarker diagnostic test kits market is poised for significant growth, driven by increasing awareness of cardiovascular diseases and advancements in diagnostic technologies. These kits are essential for early detection and management of heart-related conditions, enabling timely intervention and improving patient outcomes. The cardiac biomarker diagnostic test kits market is projected to grow at a steady CAGR of 5.70% between 2023 and 2032, reaching an estimated valuation of USD 1.89 billion by 2025 and USD 2.79 billion by 2032.

Market Insights

The demand for these diagnostic solutions is propelled by a combination of lifestyle-related health risks and an aging global population, creating an urgent need for innovative tools to address cardiovascular health challenges. The cardiac biomarker diagnostic test kits market is set to witness robust growth as demand for innovative, accurate, and timely diagnostic tools rises. With expanding opportunities in POC testing, AI integration, and emerging markets, the sector is on a trajectory to transform cardiovascular care and improve global health outcomes.

Market Drivers

1. Rising Cardiovascular Disease Prevalence: The growing incidence of cardiovascular conditions like myocardial infarction and heart failure is a major driver of market growth. Cardiac biomarker test kits enable early detection, ensuring effective management of these critical conditions.
2. Technological Advancements: Innovations in high-sensitivity assays and multiplex immunoassays have enhanced the precision and efficiency of cardiac biomarker testing, fostering increased adoption among healthcare providers.
3. Increased Healthcare Awareness: Growing awareness among healthcare professionals and patients about the importance of early detection has led to greater demand for cardiac biomarker diagnostic test kits.

Business Opportunities

1. Point-of-Care (POC) Testing: Expanding POC testing capabilities presents a significant opportunity for manufacturers. Rapid and user-friendly POC test kits allow for immediate, on-site diagnosis, catering to emergency and remote healthcare settings.
2. AI Integration: Incorporating artificial intelligence (AI) into diagnostic solutions can enhance accuracy by analyzing complex biomarker patterns and providing predictive insights. This integration positions companies at the forefront of innovation in cardiac diagnostics.
3. Emerging Markets: Growing healthcare investments and rising cardiovascular disease prevalence in regions such as South Asia and the Pacific offer untapped opportunities for market expansion.

Regional Analysis

Europe: Europe leads the global market due to its advanced healthcare infrastructure and emphasis on preventive care. The region's focus on research and adherence to clinical standards further solidifies its dominance.
South Asia and Pacific: This region is the fastest-growing market segment, driven by an increased burden of cardiovascular diseases and significant investments in healthcare infrastructure.
North America: North America remains a key market due to high awareness levels and the availability of advanced diagnostic technologies.

Key Players Leading companies in the cardiac biomarker diagnostic test kits market include:

Abbott Laboratories
Danaher Corporation
Bio-Rad Laboratories
Thermo Fisher Scientific, Inc.
Becton, Dickinson and Company
F. Hoffmann-La Roche Ltd.
Siemens AG
BioMerieux SA
Randox Laboratories Ltd.

These organizations continue to drive innovation and expand their market presence through strategic collaborations, product launches, and technological advancements.

Market Segmentation The market is segmented as follows:

By Product Type: Brain Natriuretic Peptide (BNPs) Test Kits Creatine Kinase MB (CK-MB) Test Kits Troponin (I&T) Test Kits Myoglobin Test Kits Others
By Indication: Angina Pectoris Acute Myocardial Infarction Congestive Heart Failure Others
By End-Use: Hospitals Diagnostic Laboratories Outpatient Clinics Academic & Research Institutes
By Region: North America Europe Asia Pacific Latin America Middle East & Africa

1. Executive Summary

1.1. Global Cardiac Biomarker Diagnostic Test Kits Market Snapshot
1.2. Future Projections
1.3. Key Market Trends
1.4. Regional Snapshot, by Value, 2024
1.5. Analyst Recommendations

2. Market Overview

2.1. Market Definitions and Segmentations
2.2. Market Dynamics
- 2.2.1. Drivers
- 2.2.2. Restraints
- 2.2.3. Market Opportunities
2.3. Value Chain Analysis
2.4. Porter's Five Forces Analysis
2.5. COVID-19 Impact Analysis
- 2.5.1. Supply
- 2.5.2. Demand
2.6. Impact of Ukraine-Russia Conflict
2.7. Economic Overview
- 2.7.1. World Economic Projections
2.8. PESTLE Analysis

3. Global Cardiac Biomarker Diagnostic Test Kits Market Outlook, 2019 - 2032

3.1. Global Cardiac Biomarker Diagnostic Test Kits Market Outlook, by Product Type, Value (US$ Bn), 2019 - 2032
- 3.1.1. Key Highlights
  - 3.1.1.1. Brain Natriuretic Peptide (BNPs) Test Kit
  - 3.1.1.2. Creatine Kinase MB (CK-MB) Test Kit
  - 3.1.1.3. Troponin (I&T) Test Kit
  - 3.1.1.4. Myoglobin Test Kit
  - 3.1.1.5. Others
3.2. Global Cardiac Biomarker Diagnostic Test Kits Market Outlook, by Indication, Value (US$ Bn), 2019 - 2032
- 3.2.1. Key Highlights
  - 3.2.1.1. Angina Pectoris
  - 3.2.1.2. Acute Myocardial Infarction
  - 3.2.1.3. Congestive Heart Failure
  - 3.2.1.4. Others
3.3. Global Cardiac Biomarker Diagnostic Test Kits Market Outlook, by End Use, Value (US$ Bn), 2019 - 2032
- 3.3.1. Key Highlights
  - 3.3.1.1. Hospitals
  - 3.3.1.2. Diagnostic Laboratories
  - 3.3.1.3. Outpatient Clinics
  - 3.3.1.4. Academic & Research Institutes
3.4. Global Cardiac Biomarker Diagnostic Test Kits Market Outlook, by Region, Value (US$ Bn), 2019 - 2032
- 3.4.1. Key Highlights
  - 3.4.1.1. North America
  - 3.4.1.2. Europe
  - 3.4.1.3. Asia Pacific
  - 3.4.1.4. Latin America
  - 3.4.1.5. Middle East & Africa

4. North America Cardiac Biomarker Diagnostic Test Kits Market Outlook, 2019 - 2032

4.1. North America Cardiac Biomarker Diagnostic Test Kits Market Outlook, by Product Type, Value (US$ Bn), 2019 - 2032
- 4.1.1. Key Highlights
  - 4.1.1.1. Brain Natriuretic Peptide (BNPs) Test Kit
  - 4.1.1.2. Creatine Kinase MB (CK-MB) Test Kit
  - 4.1.1.3. Troponin (I&T) Test Kit
  - 4.1.1.4. Myoglobin Test Kit
  - 4.1.1.5. Others
4.2. North America Cardiac Biomarker Diagnostic Test Kits Market Outlook, by Indication, Value (US$ Bn), 2019 - 2032
- 4.2.1. Key Highlights
  - 4.2.1.1. Angina Pectoris
  - 4.2.1.2. Acute Myocardial Infarction
  - 4.2.1.3. Congestive Heart Failure
  - 4.2.1.4. Others
4.3. North America Cardiac Biomarker Diagnostic Test Kits Market Outlook, by End Use, Value (US$ Bn), 2019 - 2032
- 4.3.1. Key Highlights
  - 4.3.1.1. Hospitals
  - 4.3.1.2. Diagnostic Laboratories
  - 4.3.1.3. Outpatient Clinics
  - 4.3.1.4. Academic & Research Institutes
- 4.3.2. BPS Analysis/Market Attractiveness Analysis
4.4. North America Cardiac Biomarker Diagnostic Test Kits Market Outlook, by Country, Value (US$ Bn), 2019 - 2032
- 4.4.1. Key Highlights
  - 4.4.1.1. U.S. Cardiac Biomarker Diagnostic Test Kits Market by Product Type, Value (US$ Bn), 2019 - 2032
  - 4.4.1.2. U.S. Cardiac Biomarker Diagnostic Test Kits Market by Indication, Value (US$ Bn), 2019 - 2032
  - 4.4.1.3. U.S. Cardiac Biomarker Diagnostic Test Kits Market by End Use, Value (US$ Bn), 2019 - 2032
  - 4.4.1.4. Canada Cardiac Biomarker Diagnostic Test Kits Market by Product Type, Value (US$ Bn), 2019 - 2032
  - 4.4.1.5. Canada Cardiac Biomarker Diagnostic Test Kits Market by Indication, Value (US$ Bn), 2019 - 2032
  - 4.4.1.6. Canada Cardiac Biomarker Diagnostic Test Kits Market by End Use, Value (US$ Bn), 2019 - 2032
- 4.4.2. BPS Analysis/Market Attractiveness Analysis

5. Europe Cardiac Biomarker Diagnostic Test Kits Market Outlook, 2019 - 2032

5.1. Europe Cardiac Biomarker Diagnostic Test Kits Market Outlook, by Product Type, Value (US$ Bn), 2019 - 2032
- 5.1.1. Key Highlights
  - 5.1.1.1. Brain Natriuretic Peptide (BNPs) Test Kit
  - 5.1.1.2. Creatine Kinase MB (CK-MB) Test Kit
  - 5.1.1.3. Troponin (I&T) Test Kit
  - 5.1.1.4. Myoglobin Test Kit
  - 5.1.1.5. Others
5.2. Europe Cardiac Biomarker Diagnostic Test Kits Market Outlook, by Indication, Value (US$ Bn), 2019 - 2032
- 5.2.1. Key Highlights
  - 5.2.1.1. Angina Pectoris
  - 5.2.1.2. Acute Myocardial Infarction
  - 5.2.1.3. Congestive Heart Failure
  - 5.2.1.4. Others
5.3. Europe Cardiac Biomarker Diagnostic Test Kits Market Outlook, by End Use, Value (US$ Bn), 2019 - 2032
- 5.3.1. Key Highlights
  - 5.3.1.1. Hospitals
  - 5.3.1.2. Diagnostic Laboratories
  - 5.3.1.3. Outpatient Clinics
  - 5.3.1.4. Academic & Research Institutes
- 5.3.2. BPS Analysis/Market Attractiveness Analysis
5.4. Europe Cardiac Biomarker Diagnostic Test Kits Market Outlook, by Country, Value (US$ Bn), 2019 - 2032
- 5.4.1. Key Highlights
  - 5.4.1.1. Germany Cardiac Biomarker Diagnostic Test Kits Market by Product Type, Value (US$ Bn), 2019 - 2032
  - 5.4.1.2. Germany Cardiac Biomarker Diagnostic Test Kits Market by Indication, Value (US$ Bn), 2019 - 2032
  - 5.4.1.3. Germany Cardiac Biomarker Diagnostic Test Kits Market by End Use, Value (US$ Bn), 2019 - 2032
  - 5.4.1.4. U.K. Cardiac Biomarker Diagnostic Test Kits Market by Product Type, Value (US$ Bn), 2019 - 2032
  - 5.4.1.5. U.K. Cardiac Biomarker Diagnostic Test Kits Market by Indication, Value (US$ Bn), 2019 - 2032
  - 5.4.1.6. U.K. Cardiac Biomarker Diagnostic Test Kits Market by End Use, Value (US$ Bn), 2019 - 2032
  - 5.4.1.7. France Cardiac Biomarker Diagnostic Test Kits Market by Product Type, Value (US$ Bn), 2019 - 2032
  - 5.4.1.8. France Cardiac Biomarker Diagnostic Test Kits Market by Indication, Value (US$ Bn), 2019 - 2032
  - 5.4.1.9. France Cardiac Biomarker Diagnostic Test Kits Market by End Use, Value (US$ Bn), 2019 - 2032
  - 5.4.1.10. Italy Cardiac Biomarker Diagnostic Test Kits Market by Product Type, Value (US$ Bn), 2019 - 2032
  - 5.4.1.11. Italy Cardiac Biomarker Diagnostic Test Kits Market by Indication, Value (US$ Bn), 2019 - 2032
  - 5.4.1.12. Italy Cardiac Biomarker Diagnostic Test Kits Market by End Use, Value (US$ Bn), 2019 - 2032
  - 5.4.1.13. Turkey Cardiac Biomarker Diagnostic Test Kits Market by Product Type, Value (US$ Bn), 2019 - 2032
  - 5.4.1.14. Turkey Cardiac Biomarker Diagnostic Test Kits Market by Indication, Value (US$ Bn), 2019 - 2032
  - 5.4.1.15. Turkey Cardiac Biomarker Diagnostic Test Kits Market by End Use, Value (US$ Bn), 2019 - 2032
  - 5.4.1.16. Russia Cardiac Biomarker Diagnostic Test Kits Market by Product Type, Value (US$ Bn), 2019 - 2032
  - 5.4.1.17. Russia Cardiac Biomarker Diagnostic Test Kits Market by Indication, Value (US$ Bn), 2019 - 2032
  - 5.4.1.18. Russia Cardiac Biomarker Diagnostic Test Kits Market by End Use, Value (US$ Bn), 2019 - 2032
  - 5.4.1.19. Rest of Europe Cardiac Biomarker Diagnostic Test Kits Market by Product Type, Value (US$ Bn), 2019 - 2032
  - 5.4.1.20. Rest of Europe Cardiac Biomarker Diagnostic Test Kits Market by Indication, Value (US$ Bn), 2019 - 2032
  - 5.4.1.21. Rest of Europe Cardiac Biomarker Diagnostic Test Kits Market by End Use, Value (US$ Bn), 2019 - 2032
- 5.4.2. BPS Analysis/Market Attractiveness Analysis

6. Asia Pacific Cardiac Biomarker Diagnostic Test Kits Market Outlook, 2019 - 2032

6.1. Asia Pacific Cardiac Biomarker Diagnostic Test Kits Market Outlook, by Product Type, Value (US$ Bn), 2019 - 2032
- 6.1.1. Key Highlights
  - 6.1.1.1. Brain Natriuretic Peptide (BNPs) Test Kit
  - 6.1.1.2. Creatine Kinase MB (CK-MB) Test Kit
  - 6.1.1.3. Troponin (I&T) Test Kit
  - 6.1.1.4. Myoglobin Test Kit
  - 6.1.1.5. Others
6.2. Asia Pacific Cardiac Biomarker Diagnostic Test Kits Market Outlook, by Indication, Value (US$ Bn), 2019 - 2032
- 6.2.1. Key Highlights
  - 6.2.1.1. Angina Pectoris
  - 6.2.1.2. Acute Myocardial Infarction
  - 6.2.1.3. Congestive Heart Failure
  - 6.2.1.4. Others
6.3. Asia Pacific Cardiac Biomarker Diagnostic Test Kits Market Outlook, by End Use, Value (US$ Bn), 2019 - 2032
- 6.3.1. Key Highlights
  - 6.3.1.1. Hospitals
  - 6.3.1.2. Diagnostic Laboratories
  - 6.3.1.3. Outpatient Clinics
  - 6.3.1.4. Academic & Research Institutes
- 6.3.2. BPS Analysis/Market Attractiveness Analysis
6.4. Asia Pacific Cardiac Biomarker Diagnostic Test Kits Market Outlook, by Country, Value (US$ Bn), 2019 - 2032
- 6.4.1. Key Highlights
  - 6.4.1.1. China Cardiac Biomarker Diagnostic Test Kits Market by Product Type, Value (US$ Bn), 2019 - 2032
  - 6.4.1.2. China Cardiac Biomarker Diagnostic Test Kits Market by Indication, Value (US$ Bn), 2019 - 2032
  - 6.4.1.3. China Cardiac Biomarker Diagnostic Test Kits Market by End Use, Value (US$ Bn), 2019 - 2032
  - 6.4.1.4. Japan Cardiac Biomarker Diagnostic Test Kits Market by Product Type, Value (US$ Bn), 2019 - 2032
  - 6.4.1.5. Japan Cardiac Biomarker Diagnostic Test Kits Market by Indication, Value (US$ Bn), 2019 - 2032
  - 6.4.1.6. Japan Cardiac Biomarker Diagnostic Test Kits Market by End Use, Value (US$ Bn), 2019 - 2032
  - 6.4.1.7. South Korea Cardiac Biomarker Diagnostic Test Kits Market by Product Type, Value (US$ Bn), 2019 - 2032
  - 6.4.1.8. South Korea Cardiac Biomarker Diagnostic Test Kits Market by Indication, Value (US$ Bn), 2019 - 2032
  - 6.4.1.9. South Korea Cardiac Biomarker Diagnostic Test Kits Market by End Use, Value (US$ Bn), 2019 - 2032
  - 6.4.1.10. India Cardiac Biomarker Diagnostic Test Kits Market by Product Type, Value (US$ Bn), 2019 - 2032
  - 6.4.1.11. India Cardiac Biomarker Diagnostic Test Kits Market by Indication, Value (US$ Bn), 2019 - 2032
  - 6.4.1.12. India Cardiac Biomarker Diagnostic Test Kits Market by End Use, Value (US$ Bn), 2019 - 2032
  - 6.4.1.13. Southeast Asia Cardiac Biomarker Diagnostic Test Kits Market by Product Type, Value (US$ Bn), 2019 - 2032
  - 6.4.1.14. Southeast Asia Cardiac Biomarker Diagnostic Test Kits Market by Indication, Value (US$ Bn), 2019 - 2032
  - 6.4.1.15. Southeast Asia Cardiac Biomarker Diagnostic Test Kits Market by End Use, Value (US$ Bn), 2019 - 2032
  - 6.4.1.16. Rest of Asia Pacific Cardiac Biomarker Diagnostic Test Kits Market by Product Type, Value (US$ Bn), 2019 - 2032
  - 6.4.1.17. Rest of Asia Pacific Cardiac Biomarker Diagnostic Test Kits Market by Indication, Value (US$ Bn), 2019 - 2032
  - 6.4.1.18. Rest of Asia Pacific Cardiac Biomarker Diagnostic Test Kits Market by End Use, Value (US$ Bn), 2019 - 2032
- 6.4.2. BPS Analysis/Market Attractiveness Analysis

7. Latin America Cardiac Biomarker Diagnostic Test Kits Market Outlook, 2019 - 2032

7.1. Latin America Cardiac Biomarker Diagnostic Test Kits Market Outlook, by Product Type, Value (US$ Bn), 2019 - 2032
- 7.1.1. Key Highlights
  - 7.1.1.1. Brain Natriuretic Peptide (BNPs) Test Kit
  - 7.1.1.2. Creatine Kinase MB (CK-MB) Test Kit
  - 7.1.1.3. Troponin (I&T) Test Kit
  - 7.1.1.4. Myoglobin Test Kit
  - 7.1.1.5. Others
7.2. Latin America Cardiac Biomarker Diagnostic Test Kits Market Outlook, by Indication, Value (US$ Bn), 2019 - 2032
7.3. Latin America Cardiac Biomarker Diagnostic Test Kits Market Outlook, by End Use, Value (US$ Bn), 2019 - 2032
- 7.3.1. Key Highlights
  - 7.3.1.1. Hospitals
  - 7.3.1.2. Diagnostic Laboratories
  - 7.3.1.3. Outpatient Clinics
  - 7.3.1.4. Academic & Research Institutes
- 7.3.2. BPS Analysis/Market Attractiveness Analysis
7.4. Latin America Cardiac Biomarker Diagnostic Test Kits Market Outlook, by Country, Value (US$ Bn), 2019 - 2032
- 7.4.1. Key Highlights
  - 7.4.1.1. Brazil Cardiac Biomarker Diagnostic Test Kits Market by Product Type, Value (US$ Bn), 2019 - 2032
  - 7.4.1.2. Brazil Cardiac Biomarker Diagnostic Test Kits Market by Indication, Value (US$ Bn), 2019 - 2032
  - 7.4.1.3. Brazil Cardiac Biomarker Diagnostic Test Kits Market by End Use, Value (US$ Bn), 2019 - 2032
  - 7.4.1.4. Mexico Cardiac Biomarker Diagnostic Test Kits Market by Product Type, Value (US$ Bn), 2019 - 2032
  - 7.4.1.5. Mexico Cardiac Biomarker Diagnostic Test Kits Market by Indication, Value (US$ Bn), 2019 - 2032
  - 7.4.1.6. Mexico Cardiac Biomarker Diagnostic Test Kits Market by End Use, Value (US$ Bn), 2019 - 2032
  - 7.4.1.7. Argentina Cardiac Biomarker Diagnostic Test Kits Market by Product Type, Value (US$ Bn), 2019 - 2032
  - 7.4.1.8. Argentina Cardiac Biomarker Diagnostic Test Kits Market by Indication, Value (US$ Bn), 2019 - 2032
  - 7.4.1.9. Argentina Cardiac Biomarker Diagnostic Test Kits Market by End Use, Value (US$ Bn), 2019 - 2032
  - 7.4.1.10. Rest of Latin America Cardiac Biomarker Diagnostic Test Kits Market by Product Type, Value (US$ Bn), 2019 - 2032
  - 7.4.1.11. Rest of Latin America Cardiac Biomarker Diagnostic Test Kits Market by Indication, Value (US$ Bn), 2019 - 2032
  - 7.4.1.12. Rest of Latin America Cardiac Biomarker Diagnostic Test Kits Market by End Use, Value (US$ Bn), 2019 - 2032
- 7.4.2. BPS Analysis/Market Attractiveness Analysis

8. Middle East & Africa Cardiac Biomarker Diagnostic Test Kits Market Outlook, 2019 - 2032

8.1. Middle East & Africa Cardiac Biomarker Diagnostic Test Kits Market Outlook, by Product Type, Value (US$ Bn), 2019 - 2032
- 8.1.1. Key Highlights
  - 8.1.1.1. Brain Natriuretic Peptide (BNPs) Test Kit
  - 8.1.1.2. Creatine Kinase MB (CK-MB) Test Kit
  - 8.1.1.3. Troponin (I&T) Test Kit
  - 8.1.1.4. Myoglobin Test Kit
  - 8.1.1.5. Others
8.2. Middle East & Africa Cardiac Biomarker Diagnostic Test Kits Market Outlook, by Indication, Value (US$ Bn), 2019 - 2032
- 8.2.1. Key Highlights
  - 8.2.1.1. Angina Pectoris
  - 8.2.1.2. Acute Myocardial Infarction
  - 8.2.1.3. Congestive Heart Failure
  - 8.2.1.4. Others
8.3. Middle East & Africa Cardiac Biomarker Diagnostic Test Kits Market Outlook, by End Use, Value (US$ Bn), 2019 - 2032
- 8.3.1. Key Highlights
  - 8.3.1.1. Hospitals
  - 8.3.1.2. Diagnostic Laboratories
  - 8.3.1.3. Outpatient Clinics
  - 8.3.1.4. Academic & Research Institutes
- 8.3.2. BPS Analysis/Market Attractiveness Analysis
8.4. Middle East & Africa Cardiac Biomarker Diagnostic Test Kits Market Outlook, by Country, Value (US$ Bn), 2019 - 2032
- 8.4.1. Key Highlights
  - 8.4.1.1. GCC Cardiac Biomarker Diagnostic Test Kits Market by Product Type, Value (US$ Bn), 2019 - 2032
  - 8.4.1.2. GCC Cardiac Biomarker Diagnostic Test Kits Market by Indication, Value (US$ Bn), 2019 - 2032
  - 8.4.1.3. GCC Cardiac Biomarker Diagnostic Test Kits Market by End Use, Value (US$ Bn), 2019 - 2032
  - 8.4.1.4. South Africa Cardiac Biomarker Diagnostic Test Kits Market by Product Type, Value (US$ Bn), 2019 - 2032
  - 8.4.1.5. South Africa Cardiac Biomarker Diagnostic Test Kits Market by Indication, Value (US$ Bn), 2019 - 2032
  - 8.4.1.6. South Africa Cardiac Biomarker Diagnostic Test Kits Market by End Use, Value (US$ Bn), 2019 - 2032
  - 8.4.1.7. Egypt Cardiac Biomarker Diagnostic Test Kits Market by Product Type, Value (US$ Bn), 2019 - 2032
  - 8.4.1.8. Egypt Cardiac Biomarker Diagnostic Test Kits Market by Indication, Value (US$ Bn), 2019 - 2032
  - 8.4.1.9. Egypt Cardiac Biomarker Diagnostic Test Kits Market by End Use, Value (US$ Bn), 2019 - 2032
  - 8.4.1.10. Nigeria Cardiac Biomarker Diagnostic Test Kits Market by Product Type, Value (US$ Bn), 2019 - 2032
  - 8.4.1.11. Nigeria Cardiac Biomarker Diagnostic Test Kits Market by Indication, Value (US$ Bn), 2019 - 2032
  - 8.4.1.12. Nigeria Cardiac Biomarker Diagnostic Test Kits Market by End Use, Value (US$ Bn), 2019 - 2032
  - 8.4.1.13. Rest of Middle East & Africa Cardiac Biomarker Diagnostic Test Kits Market by Product Type, Value (US$ Bn), 2019 - 2032
  - 8.4.1.14. Rest of Middle East & Africa Cardiac Biomarker Diagnostic Test Kits Market by Indication, Value (US$ Bn), 2019 - 2032
  - 8.4.1.15. Rest of Middle East & Africa Cardiac Biomarker Diagnostic Test Kits Market by End Use, Value (US$ Bn), 2019 - 2032
- 8.4.2. BPS Analysis/Market Attractiveness Analysis

9. Competitive Landscape

9.1. By End Use vs by Indication Heat map
9.2. Manufacturer vs by Indication Heatmap
9.3. Company Market Share Analysis, 2024
9.4. Competitive Dashboard
9.5. Company Profiles
- 9.5.1. Abbott Laboratories
  - 9.5.1.1. Company Overview
  - 9.5.1.2. Product Portfolio
  - 9.5.1.3. Financial Overview
  - 9.5.1.4. Business Strategies and Development
- 9.5.2. Danaher Corporation
- 9.5.3. Bio-Rad Laboratories
- 9.5.4. Thermo Fisher Scientific, Inc.
- 9.5.5. Becton, Dickinson and Company
- 9.5.6. F. Hoffmann-La Roche Ltd.
- 9.5.7. Siemens AG
- 9.5.8. BioMerieux SA
- 9.5.9. Randox Laboratories Ltd.
- 9.5.10. Others

10. Appendix

10.1. Research Methodology
10.2. Report Assumptions
10.3. Acronyms and Abbreviations